Company’s pipeline includes two NDA-stage respiratory compounds that will compete in the multi-billion dollar allergy and asthma steroid markets MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Acton ...
Paris, France, July 31, 2013 — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration's (FDA) Nonprescription Drugs Advisory Committee (NDAC) voted 10 to 6, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results